213 related articles for article (PubMed ID: 24709261)
1. Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
Hayakawa K; Miyoshi-Akiyama T; Kirikae T; Nagamatsu M; Shimada K; Mezaki K; Sugiki Y; Kuroda E; Kubota S; Takeshita N; Kutsuna S; Tojo M; Ohmagari N
Antimicrob Agents Chemother; 2014 Jun; 58(6):3441-50. PubMed ID: 24709261
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genomic characteristics of IMP-producing
Suzuki D; Sakurai A; Wakuda M; Suzuki M; Doi Y
Antimicrob Agents Chemother; 2024 May; 68(5):e0167223. PubMed ID: 38517188
[TBL] [Abstract][Full Text] [Related]
3. Molecular Characterization of IMP-1-Producing Enterobacter cloacae Complex Isolates in Tokyo.
Aoki K; Harada S; Yahara K; Ishii Y; Motooka D; Nakamura S; Akeda Y; Iida T; Tomono K; Iwata S; Moriya K; Tateda K
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311089
[TBL] [Abstract][Full Text] [Related]
4. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiological analysis and risk factors for acquisition of carbapenemase-producing
Tetsuka N; Hirabayashi A; Matsumoto A; Oka K; Hara Y; Morioka H; Iguchi M; Tomita Y; Suzuki M; Shibayama K; Yagi T
Antimicrob Resist Infect Control; 2019; 8():126. PubMed ID: 31367347
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of
Miyoshi-Akiyama T; Ohmagari N; Phuong TT; Huy NQ; Anh NQ; Van Thanh D; Thuy PTP; Kirikae T; Nhung PH; Takemoto N
J Med Microbiol; 2020 Apr; 69(4):530-536. PubMed ID: 32216869
[No Abstract] [Full Text] [Related]
7. Three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection in Japan.
Hamada Y; Watanabe K; Tada T; Mezaki K; Takeuchi S; Shimizu T; Kirikae T; Ohmagari N
J Infect Chemother; 2013 Oct; 19(5):956-8. PubMed ID: 23160627
[TBL] [Abstract][Full Text] [Related]
8. Institutional outbreak involving multiple clades of IMP-producing Enterobacter cloacae complex sequence type 78 at a cancer center in Tokyo, Japan.
Harada S; Aoki K; Ohkushi D; Okamoto K; Takehana K; Akatsuchi T; Ida K; Shoji D; Ishii Y; Doi Y; Moriya K; Hayama B
BMC Infect Dis; 2021 Mar; 21(1):289. PubMed ID: 33752612
[TBL] [Abstract][Full Text] [Related]
9. Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases.
Pang F; Jia XQ; Wang B; Li YH; Zhao QG
Pathol Biol (Paris); 2014 Jun; 62(3):152-5. PubMed ID: 24685523
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia.
Novak A; Goic-Barisic I; Andrasevic AT; Butic I; Radic M; Jelic M; Rubic Z; Tonkic M
Microb Drug Resist; 2014 Oct; 20(5):399-403. PubMed ID: 24716493
[TBL] [Abstract][Full Text] [Related]
11. Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii.
Yan JJ; Ko WC; Chuang CL; Wu JJ
J Antimicrob Chemother; 2002 Oct; 50(4):503-11. PubMed ID: 12356794
[TBL] [Abstract][Full Text] [Related]
12. Outbreak of New Delhi metallo-β-lactamase-1-producing Enterobacter cloacae in an acute care hospital general ward in Singapore.
Ho HJ; Toh CY; Ang B; Krishnan P; Lin RT; La MV; Chow A
Am J Infect Control; 2016 Feb; 44(2):177-82. PubMed ID: 26454748
[TBL] [Abstract][Full Text] [Related]
13. Modified Hodge test using Mueller-Hinton agar supplemented with cloxacillin improves screening for carbapenemase-producing clinical isolates of Enterobacteriaceae.
Takayama Y; Adachi Y; Nihonyanagi S; Okamoto R
J Med Microbiol; 2015 Jul; 64(7):774-777. PubMed ID: 25934552
[TBL] [Abstract][Full Text] [Related]
14. Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.
Sidjabat HE; Townell N; Nimmo GR; George NM; Robson J; Vohra R; Davis L; Heney C; Paterson DL
Antimicrob Agents Chemother; 2015 Jul; 59(7):4059-66. PubMed ID: 25918153
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain).
Treviño M; Moldes L; Martínez-Lamas L; Varón C; Regueiro BJ
Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1253-8. PubMed ID: 19504135
[TBL] [Abstract][Full Text] [Related]
16. Survey of Clinical Extended-Spectrum Beta-Lactamase-Producing Enterobacter cloacae Isolates in a Chinese Tertiary Hospital, 2012-2014.
Cao XL; Cheng L; Zhang ZF; Ning MZ; Zhou WQ; Zhang K; Shen H
Microb Drug Resist; 2017 Jan; 23(1):83-89. PubMed ID: 27116016
[TBL] [Abstract][Full Text] [Related]
17. Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
Miltgen G; Bonnin RA; Avril C; Benoit-Cattin T; Martak D; Leclaire A; Traversier N; Roquebert B; Jaffar-Bandjee MC; Lugagne N; Filleul L; Subiros M; de Montera AM; Cholley P; Thouverez M; Dortet L; Bertrand X; Naas T; Hocquet D; Belmonte O
Int J Antimicrob Agents; 2018 Sep; 52(3):416-420. PubMed ID: 29807164
[TBL] [Abstract][Full Text] [Related]
18. IMI-Type Carbapenemase-Producing Enterobacter cloacae Complex, France and Overseas Regions, 2012-2022.
Emeraud C; Girlich D; Deschamps M; Rezzoug I; Jacquemin A; Jousset AB; Lecolant S; Locher L; Birer A; Naas T; Bonnin RA; Dortet L
Emerg Infect Dis; 2024 Jun; 30(6):1279-1282. PubMed ID: 38782383
[TBL] [Abstract][Full Text] [Related]
19. IMP metallo-β-lactamase-producing clinical isolates of Enterobacter cloacae in the UK.
Shet V; Gouliouris T; Brown NM; Turton JF; Zhang J; Woodford N
J Antimicrob Chemother; 2011 Jun; 66(6):1408-9. PubMed ID: 21393151
[No Abstract] [Full Text] [Related]
20. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y
Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
